The Latest Breaking News from Disease

A successful claim for Attendance Allowance is worth either £247.40 or £369.60 every four weeks.

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Some Australian native plants — including paperbarks, lilly pillies, eucalypts and bottlebrush — are grappling with their own pandemic as the exotic myrtle rust fungus spreads.

Routine childhood immunisations have dropped so dramatically globally during the COVID-19 pandemic that the World Health Organization and UNICEF are raising the alarm.

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT

Officials may expand bans on foods being brought in from Indonesia by travellers as the situation with foot and mouth disease evolves, an inquiry has been told.

There isn't currently a Lyme disease vaccine on the U.S. market. Researchers are hoping to change that.

Imagine a patient with a rare genetic disorder that makes their arms and legs have imprecise and slow movements. For years, the patient has faced serious restrictions in day-to-day life. They tried several treatments, but all have failed to ease the symptoms.

Filmmaker Lars von Trier has been diagnosed with Parkinson's disease and is in "good spirits" while being treated for the symptoms of the brain disorder.